| Announce Date | 11/06/2025 |
| EPS Normalized Actual | $0.703 (Miss by $-0.017) |
| EPS GAAP Actual | $0.703 (Miss by $-0.017) |
| Revenue Actual | $0.330345B |
| Revenue Surprise | Beat by $330.345M |
| Announce Date | 12/31/1969 (Pre-Market) |
| EPS Normalized Estimate | $ |
| EPS GAAP Estimate | $ |
| Revenue Estimate | $0B |
| Fiscal Period Ending | EPS Estimate | Forward PE | Low | High | # of Analysts |
|---|---|---|---|---|---|
| Dec 2029 | 4.94 | 18.63 | 4.7699 | 5.12278 | 1 |
| Dec 2028 | 4.4 | 20.92 | 4.24849 | 4.5628 | 1 |
| Period | EPS | Beat / Miss | Revenue | YoY | Beat / Miss |
|---|---|---|---|---|---|
| FQ3 2025 (Sep 2025) | 0.7044 | 0.7044 | 0.330345B | 11.53% | 330.35M |
| FQ2 2025 (Jun 2025) | 0.69 | 0.69 | 0.340879B | 11.72% | 340.88M |
| FQ1 2025 (Mar 2025) | 0.5 | 0.5 | 0.276662B | 10.35% | 276.66M |
| FQ4 2024 (Dec 2024) | 0.56 | 0.56 | 0.34045B | 16.26% | 340.45M |
| FQ3 2024 (Sep 2024) | 0.5 | 0.5 | 0.292246B | 5.03% | 292.25M |
| FQ2 2024 (Jun 2024) | 0.56 | 0.56 | 0.300941B | 4.81% | 300.94M |
| FQ1 2024 (Mar 2024) | 0.39 | 0.39 | 0.248017B | 10.4% | 248.02M |
| FQ4 2023 (Dec 2023) | 0.41 | 0.41 | 0.285086B | 1.34% | 285.09M |
FQ4 Announce Date
12/31/1969 (Pre-Market)
Consensus EPS Estimates
Consensus Revenue Estimates
0B
| Fiscal Period Ending | EPS Estimate | YoY Growth(%) | Low | High | # of Analysts |
|---|---|---|---|---|---|
| FQ4 2027 (Dec 2027) | 1.13353 | -- | 1.08793 | 1.18635 | 4 |
| FQ3 2027 (Sep 2027) | 1.09939 | -- | 1.05517 | 1.15062 | 4 |
| FQ2 2027 (Jun 2027) | 1.18799 | -- | 1.1402 | 1.24335 | 4 |
| FQ1 2027 (Mar 2027) | 0.8299 | -- | 0.79652 | 0.86857 | 4 |
| FQ4 2026 (Oct 2026) | 0.78512 | -- | 0.73741 | 0.82548 | 9 |
| FQ3 2026 (Jul 2026) | 0.86563 | 18.63 | 0.81303 | 0.91013 | 9 |
| FQ2 2026 (Jun 2026) | 0.98214 | 29.75 | 0.94263 | 1.02791 | 4 |
| Fiscal Period Ending | Revenue Estimate | YoY Growth(%) | Low | High | # of Analysts |
|---|---|---|---|---|---|
| FQ4 2027 (Dec 2027) | 0.46B | -- | 0.44B | 0.47B | 5 |
| FQ3 2027 (Sep 2027) | 0.41B | -- | 0.4B | 0.43B | 5 |
| FQ2 2027 (Jun 2027) | 0.42B | -- | 0.41B | 0.44B | 5 |
| FQ1 2027 (Mar 2027) | 0.36B | -- | 0.35B | 0.37B | 5 |
| FQ4 2026 (Oct 2026) | 0.34B | -- | 0.32B | 0.35B | 10 |
| FQ3 2026 (Jul 2026) | 0.34B | 3.83 | 0.33B | 0.36B | 10 |
| FQ2 2026 (Jun 2026) | 0.38B | 9.52 | 0.37B | 0.39B | 5 |
EPS # of Up Revisions
4
EPS # of Down Revisions
4
Revenue # of Up Revisions
6
Revenue # of Down Revisions
3
| Fiscal Period Ending | EPS Estimate | YoY Growth | Low | High | # of Analysts |
|---|---|---|---|---|---|
| FQ4 2021 (Dec 2021) | 0.41 | -12.52% | 0.39 | 0.48 | 20 |
| FQ1 2022 (Mar 2022) | 0.59 | 6.89% | 0.55 | 0.62 | 15 |
| FQ2 2022 (Jun 2022) | 0.70 | 2.62% | 0.61 | 0.74 | 15 |
| FQ3 2022 (Sep 2022) | 0.68 | 4.62% | 0.65 | 0.70 | 15 |
| Fiscal Period Ending | EPS Estimate | YoY Growth | Low | High | # of Analysts |
|---|---|---|---|---|---|
| FQ4 2021 (Dec 2021) | 0.41 | -12.52% | 0.39 | 0.48 | 20 |
| FQ1 2022 (Mar 2022) | 0.59 | 6.89% | 0.55 | 0.62 | 15 |
| FQ2 2022 (Jun 2022) | 0.70 | 2.62% | 0.61 | 0.74 | 15 |
| FQ3 2022 (Sep 2022) | 0.68 | 4.62% | 0.65 | 0.70 | 15 |
EPS # of Beats
8
EPS # of Misses
0
EPS # of in-lines
0
Revenue # of Beats
8
Revenue # of Misses
0
Revenue # of in-lines
0
| Earnings Date | EPS Estimate | EPS Actual | Surprise | Surprise % |
|---|---|---|---|---|
| FQ3 2025 (Sep 2025) | 0.7044 | 0.7044 | 100% | |
| FQ2 2025 (Jun 2025) | 0.69 | 0.69 | 100% | |
| FQ1 2025 (Mar 2025) | 0.5 | 0.5 | 100% | |
| FQ4 2024 (Dec 2024) | 0.56 | 0.56 | 100% | |
| FQ3 2024 (Sep 2024) | 0.5 | 0.5 | 100% | |
| FQ2 2024 (Jun 2024) | 0.56 | 0.56 | 100% | |
| FQ1 2024 (Mar 2024) | 0.39 | 0.39 | 100% | |
| FQ4 2023 (Dec 2023) | 0.41 | 0.41 | 100% |
| Earnings Date | Revenue Estimate | Revenue Actual | Surprise | Surprise % |
|---|---|---|---|---|
| FQ3 2025 (Sep 2025) | $0B | $0.33B | $330.35M | 100% |
| FQ2 2025 (Jun 2025) | $0B | $0.34B | $340.88M | 100% |
| FQ1 2025 (Mar 2025) | $0B | $0.28B | $276.66M | 100% |
| FQ4 2024 (Dec 2024) | $0B | $0.34B | $340.45M | 100% |
| FQ3 2024 (Sep 2024) | $0B | $0.29B | $292.25M | 100% |
| FQ2 2024 (Jun 2024) | $0B | $0.3B | $300.94M | 100% |
| FQ1 2024 (Mar 2024) | $0B | $0.25B | $248.02M | 100% |
| FQ4 2023 (Dec 2023) | $0B | $0.29B | $285.09M | 100% |